| | Identification | Back Directory |  | [Name] 
 (S)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride
 |  | [CAS] 
 2254176-11-7
 |  | [Synonyms] 
 Levofloxacin Impurity 2 H
 Levofloxacin Hydrochloride Impurity A
 Levofloxacin Hydrochloride Impurity A(117707-40-1 Free base)
 (S)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride
 |  | [Molecular Formula] 
 C17H19ClFN3O4
 |  | [MOL File] 
 2254176-11-7.mol
 |  | [Molecular Weight] 
 383.8
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 Desmethyl Levofloxacin hydrochloride is an antibacterial agent with broad-spectrum antibacterial activity against a variety of pathogens. Desmethyl Levofloxacin hydrochloride effectively fights bacterial infections by inhibiting bacterial DNA synthesis. Studies on Desmethyl Levofloxacin hydrochloride have shown that it has potential in inhibiting respiratory infections[1].
 |  | [References] 
 [1] Siva, R., et al., Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial. Int J Chron Obstruct Pulmon Dis, 2014. 9: p. 179-86. DOI:10.2147/COPD.S55419
 [2] Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial DOI:10.2147/COPD.S55419
 | 
 |  |